Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat-containing protein 38 (WDR38) is a human protein encoded by the WDR38 gene. WDR38 belongs to the WD-repeat protein family, which is characterized by the presence of WD repeats—a highly conserved motif that typically folds into a beta-propeller structure, allowing the protein to serve as a stable platform for protein-protein interactions[1][2][4][5]. WDR38 is predicted to act upstream in the differentiation of hematopoietic progenitor cells but does not possess enzyme activity or function as a receptor, transporter, or typical therapeutic drug target. Members of the WD-repeat family are involved in many aspects of cell biology, including the assembly of multi-protein complexes and diverse signaling processes, but WDR38's specific cellular roles and disease associations remain only partially characterized[1][2][5]. There are no known drugs or chemical modulators targeting WDR38 to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat-containing protein 38 (WDR38).